DiPerna Paul 4
4 · Modular Medical, Inc. · Filed May 18, 2026
Research Summary
AI-generated summary of this filing
Modular Medical (MODD) Chairman Paul DiPerna Receives Option Award
What Happened
Paul DiPerna — who is listed as Chairman, President, Chief Financial Officer and Treasurer of Modular Medical, Inc. (MODD) — was granted a derivative award (an option-type grant) covering 11,218 shares on May 14, 2026. The Form 4 reports the acquisition at $0.00 (no cash paid) and shows $0 total value in the filing because this is a grant of a derivative security rather than a cash purchase.
Key Details
- Transaction date: 2026-05-14; Form filed: 2026-05-18 (timely, no late-filing flag).
- Transaction type: A = Award/Grant of a derivative security (option grant).
- Shares/units granted: 11,218 (acquired @ $0.00 per the filing).
- Vesting (Footnote F1): 1/3 of the option vests on May 14, 2027, then the remainder vests monthly at 1/36th increments thereafter per the footnote.
- Beneficial ownership after transaction: not specified in the provided excerpt; footnote F2 notes column 9 reports total beneficial ownership for the class of derivative security.
- No immediate sale or exercise reported in this filing.
Context
This is a compensation-related derivative award to a senior executive, not an open-market purchase or sale. Such grants are common for executives and vest over time; they do not represent immediate proceeds unless and until the option is exercised and/or shares are sold. For retail investors, purchases or open-market insider buys are often a stronger direct signal of personal conviction than routine option grants, which are typically part of pay packages.
Insider Transaction Report
- Award
Option to purchase common stock
[F1][F2]2026-05-14+11,218→ 11,218 totalExercise: $3.46Exp: 2036-05-14→ Common Stock (11,218 underlying)
Footnotes (2)
- [F1]This option shall vest as to 1/3rd of the shares subject to the option on May 14, 2027 and as to 1/36th of the shares subject to the option on a monthly basis thereafter.
- [F2]In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in Column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."